Multiple intracellular and nucleic acid targets

The term "Multiple intracellular and nucleic acid targets" refers to a broad pharmacological profile where a therapeutic agent exerts its effects by interacting with various cellular components, primarily genomic DNA and various RNA species, rather than a single protein receptor or enzyme. This mechanism is characteristic of many traditional cytotoxic chemotherapies, such as alkylating agents, platinum-based compounds, and intercalating antibiotics, which disrupt the structural integrity of nucleic acids to inhibit replication and transcription (StatPearls, 2023). By targeting the fundamental machinery of cell division and protein synthesis, these agents are effective against rapidly proliferating cells, making them staples in oncology and certain severe autoimmune treatments (NCI, 2022). However, the lack of specificity inherent in targeting ubiquitous nucleic acids leads to significant safety challenges, including genotoxicity, myelosuppression, and the risk of secondary malignancies (ACS, 2024). Understanding this multi-target interaction is crucial for managing the narrow therapeutic window and systemic side effects associated with these potent compounds.

Other names

Non-specific intracellular targetsNucleic acid targetsDNA and RNA targetsMulti-target cytotoxic mechanism

Interference with DNA and RNA structure and function through covalent modification (alkylation), intercalation between base pairs, or formation of DNA cross-links, leading to the inhibition of replication and transcription and the induction of apoptosis.